These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 19624495

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure control in kidney transplantation: therapeutic implications.
    Premasathian NC, Muehrer R, Brazy PC, Pirsch JD, Becker BN.
    J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
    [Abstract] [Full Text] [Related]

  • 4. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
    Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L.
    Clin Transplant; 2008 Dec; 22(4):439-46. PubMed ID: 18318741
    [Abstract] [Full Text] [Related]

  • 5. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Fang W, Oreopoulos DG, Bargman JM.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.
    Kidney Blood Press Res; 2009 Nov; 32(4):268-75. PubMed ID: 19776644
    [Abstract] [Full Text] [Related]

  • 8. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
    Montanaro D, Gropuzzo M, Tulissi P, Vallone C, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Bresadola F, Mioni G.
    Transplant Proc; 2005 Mar; 37(2):991-3. PubMed ID: 15848600
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 14. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 15. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE, McNamee PT, Nelson WE, Maxwell AP.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
    Formica RN, Friedman AL, Lorber MI, Bia MJ.
    Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J.
    Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
    [Abstract] [Full Text] [Related]

  • 18. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S, Yagi S, Yamamoto H, Yamaguchi M, Izumida T, Noguchi Y, Inaba M, Inukai K.
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
    Alhadad A, Mattiasson I, Ivancev K, Lindblad B, Gottsäter A.
    Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.